TBPH vs REGN: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Regeneron Pharmaceuticals Inc in 2026
TBPH
Theravance Biopharma Inc
—
REGN
Regeneron Pharmaceuticals Inc
$632.90
Key Metrics Comparison
| Metric | TBPH | REGN | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $59.10B | REGN |
| P/E Ratio | 7.49 | 13.91 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or REGN a better investment?
Comparing TBPH and REGN: Theravance Biopharma Inc has a market cap of $861.45M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and REGN?
TBPH (Theravance Biopharma Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or REGN?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 13.9x).
Which is growing faster: TBPH or REGN?
Both TBPH and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $861.45M for TBPH.
Should I buy TBPH or REGN in 2026?
Both TBPH and REGN have investment merit. TBPH trades at $N/A while REGN trades at $632.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and REGN stock?
Key differences: Market Cap ($861.45M vs $59.10B), P/E Ratio (7.5x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or REGN in 2026?
The choice between TBPH and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and REGN?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.